Ebola Update

As the number of people infected with the deadly virus in West Africa surpasses 10,000, some countries seek to protect themselves against imported infections, while researchers race to bring vaccines to the hardest-hit nations.

Written byJef Akst
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Ebola virus particlesFLICKR, NIAIDThe Ebola virus continues to wreak havoc on the West African countries of Guinea, Liberia, and Sierra Leone: more than 10,000 people have contracted the disease and nearly 5,000 have died, the World Health Organization (WHO) announced on Saturday (October 25). Outside of these three countries, cases of the virus remain relatively sparse, with a total of just 27 infections and three deaths, but authorities around the world remain cautious.

The African country of Mali, which borders Guinea, joins to the list of countries that have now imported Ebola patients. A 2-year-old girl accompanied her grandmother on bus trip from Guinea to Mali, a several hundred mile journey throughout which the young girl was showing symptoms of an Ebola infection, authorities announced. “WHO is treating the situation in Mali as an emergency,” the agency said in a statement last week (October 24). “The child’s symptomatic state during the bus journey is especially concerning, as it presented multiple opportunities for exposures—including high-risk exposures—involving many people.”

To prevent the importation of Ebola to the United States, governors of New York, New Jersey, Illinois and other states have called for mandatory quarantines for anyone entering the country from ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies